Cours Sonoma Pharmaceuticals Inc Nasdaq
Actions
US83558L1052
Produits pharmaceutiques
CA 2024 * | 14,7 M 13,26 M | CA 2025 * | 17,9 M 16,14 M | Capitalisation | 2,36 M 2,13 M |
---|---|---|---|---|---|
Résultat net 2024 * | -5 M -4,51 M | Résultat net 2025 * | -3 M -2,71 M | VE / CA 2024 * | 0,16 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 0,13 x |
PER 2024 * |
-0,17
x | PER 2025 * |
-0,34
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 98,44% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Amy Trombly
CEO | Chief Executive Officer | 57 | 27/09/19 |
John Poggetto
DFI | Director of Finance/CFO | 53 | 01/01/02 |
Jerome Dvonch
DFI | Director of Finance/CFO | 56 | 08/09/20 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Amy Trombly
CEO | Chief Executive Officer | 57 | 27/09/19 |
Jay Birnbaum
BRD | Director/Board Member | 79 | 20/04/07 |
Director/Board Member | 64 | 19/09/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+31,37% | 588 Md | |
-2,60% | 364 Md | |
+20,83% | 326 Md | |
+5,69% | 285 Md | |
+14,83% | 239 Md | |
+9,93% | 210 Md | |
-6,95% | 200 Md | |
+10,77% | 167 Md | |
+0,10% | 161 Md |